Liprin β2 Activators
The class of Liprin β2 Activators would encompass chemicals that indirectly influence the function of Liprin β2 by acting on related signaling pathways and cellular processes. The majority of these chemicals are not direct activators of Liprin β2 but instead affect upstream regulators or components of pathways that Liprin β2 is involved in, such as synaptic signaling and cytoskeletal dynamics. These compounds generally modulate second messengers like cAMP or affect the activity of enzymes that regulate the cytoskeleton, such as kinases, phosphodiesterases, or cytoskeletal proteins themselves.
The activation or inhibition of these enzymes and regulatory proteins leads to alterations in the phosphorylation status of downstream substrates, changes in cytoskeletal organization, or modulation of synaptic structure and function-all processes where Liprin β2 plays a role. For example, forskolin and phosphodiesterase inhibitors like IBMX and Rolipram act to increase cAMP levels, indirectly promoting the activity of PKA and other cAMP-dependent processes that could impact the proteins interacting with or regulated by Liprin β2. On the other hand, compounds like Y-27632, Blebbistatin, and ML-7 act more directly on the cytoskeleton by affecting actin and myosin dynamics or inhibiting kinases like ROCK and MLCK, which are known to be key in regulating synaptic structures where Liprin β2 is localized.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels. Elevated cAMP can activate PKA, which can phosphorylate substrates that modulate synaptic function and plasticity, processes where Liprin β2 is involved. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. Enhanced cAMP/cGMP signaling can promote the activity of kinases that modulate the cytoskeleton and associated proteins, like Liprin β2. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, which specifically increases cAMP levels. The resulting activation of cAMP-dependent pathways can influence the neuronal architecture where Liprin β2 functions. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide inhibits phosphodiesterase 3, increasing cAMP in cells. Elevated cAMP can engage in signaling cascades that affect synaptic components, potentially altering Liprin β2 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, affecting the actin cytoskeleton dynamics. Since Liprin β2 is associated with the regulation of cytoskeletal dynamics, inhibition of ROCK can lead to changes in synapse structure and function, impacting Liprin β2's role. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin inhibits myosin II ATPase activity. This can influence actin-myosin interactions and thus potentially affect the cytoskeletal organization and synaptic structures where Liprin β2 operates. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 inhibits myosin light chain kinase (MLCK), impacting actin-myosin contraction. As Liprin β2 is involved in the regulation of the cytoskeleton at synapses, altering MLCK activity can indirectly affect its function. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is an inhibitor of N-WASP, a regulator of actin polymerization. Inhibiting N-WASP can change the dynamics of actin remodeling, which is a cellular process that Liprin β2 is implicated in at neuronal synapses. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and prevents their polymerization. Disruption of actin dynamics can lead to alterations in the synaptic structures and function where Liprin β2 has a role. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can lead to changes in the cytoskeleton, which could affect synaptic components and potentially influence the function of Liprin β2. | ||||||